The Smart Air Conditioning Market Size was valued at USD 17.02 Billion in 2024 and is expected to reach USD 46.39 Billion by 2032, growing at a 13.2% CAGR from 2025 to 2032. The report comprises of ...

Precise emulation is transforming BMS testing by eliminating the inefficiencies of traditional methods, enabling engineers to simulate charge and discharge cycles rapidly and safely. Automotive ...

Trane Technologies plc designs, manufactures, sells, and services of solutions for heating, ventilation, air conditioning, and custom and transport refrigeration. It offers air conditioners ...

Details on a BMS based on electrochemical impedance spectroscopy (EIS). BMS advances to keep pace with EV rising complexity. Building better battery models based on EIS characterization.

Bristol Myers Squibb is levering Fulcrum Therapeutics out of its life. MyoKardia, a biotech BMS bought in 2020, was working with Fulcrum to find cardiomyopathy targets but recently decided to end ...

2seventy has been slimming down since the fall of 2023 until it was left with nothing else but the Abecma partnership with BMS. The Cambridge, Massachusetts-based biotech had divested its cell ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab – was unable to improve on Opdivo alone in the RELATIVITY-098 ...

BMS said it will launch Cobenfy within the next few weeks and has set a price of $1,850 per month for the medicine, which is considerably more than the current, largely generic array of ...

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology ...

BMS and 2seventy bio first teamed up in 2021. Credit: Moyo Studio via Getty Images. Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at ...